All Stories

  1. Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis
  2. Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study
  3. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study
  4. Biomarkers for evaluation of mast cell and basophil activation
  5. Targeted therapy in severe asthma today: focus on immunoglobulin E
  6. Evaluation of vaccination safety in children with mastocytosis
  7. Oxidative stress markers are increased in patients with mastocytosis